K-9 Lotto dies after medical emergency, Lenexa Police Department says
The police department announced Lotto's passing about a week ago on Facebook.
According to police, Lotto experienced a sudden medical event, which led to the K-9's death.
The 2-year-old Belgian Malinois served alongside Corporal Tschippert for one year, the police department said.
'In that time, he played a vital role in narcotics detection and suspect apprehension—serving our department and community with exceptional loyalty, energy, and heart,' the Lenexa Police Department said on Facebook.
'His loss is deeply felt by all who knew him.'
The police department said Lotto had lived with Corporal Tschippert as both a working partner and a beloved companion.
'The bond between a handler and their K9 is powerful, and our department mourns this loss alongside Corporal Tschippert,' the police department said.
'Rest easy, K9 Lotto. You served with honor, and you will never be forgotten.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
APD: Fatal crash at William Cannon Dr. intersection causes closures for ‘extended period of time'
AUSTIN (KXAN) — The Austin Police Department responded to a fatal crash involving two vehicles in south Austin Monday afternoon. Police said the crash occurred around 4:51 p.m. in the intersection of S. 1st Street and W. William Cannon Drive, a social media post from Austin Police said. The crash caused lane closures in the area. Street closures at S. 1st St. northbound from Buckingham Place and William Cannon Drive eastbound will be closed, the post said. The intersection is expected to stay closed for an extended period of time, police said. 'Expect delays, plan your route,' police said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
NBC News
3 hours ago
- NBC News
Massive Medicube skin care sale: Get its viral collagen masks, pore pads and more up to 52% off on Amazon right now
There are a lot of popular beauty brands blowing up on my social media feed right now. But none are quite as ubiquitous as Medicube, the beloved K-beauty brand known for its pore pads, vitamin C capsules, exosomes and sunscreen. Right now, the brand has several deals on many of its most sought-after products on Amazon, all up to 52% off. Below, I highlight some of the best on-sale products from Medicube and why they're worth trying out. Deal of the Day These pore pads have two textures: a soft side that hydrates the skin and a more textured side to exfoliate the skin, remove dead skin cells and reduce the appearance of large pores, according to the brand. They have alpha hydroxy acids (AHAs) derived from fruit complexes and beta hydroxy acids (BHAs) which have anti-inflammatory properties that help remove excess sebum and smooth skin. Each container comes with 70 pads and you can also get the pads with different formulas, like vitamin C and exosome pads. Exosomes are organic vesicles released by cells, including skin cells, that carry protein and lipids, and in turn dictate how cells should behave. For example, think of them as messenger cells — for skin cells, they deliver instructions to help calm inflammation, repair damaged tissue and increase collagen and elastin production, according to experts we spoke to during previous reporting on the ingredient. This exosome serum from Medicube helps reduce the appearance of pores, enhance the skin barrier and smooth skin texture, which is why the brand also calls it a form of 'liquid microneedling.' The brand recommends applying the product after cleansing and before putting on moisturizer. Collagen masks are becoming increasingly popular, and this one from Medicube is enhanced by polydeoxyribonucleotide (PDRN), a chemical derived from salmon DNA that evens skin tone and strengthens the skin barrier, according to Medicube. The mask starts pink and turns clear after a few hours once the ingredients absorb into the skin. All of the products below have at least a 4-star average rating from 500 reviews or more on Amazon. Why trust NBC Select? I'm a commerce editor at NBC Select, where I write about deals and sale events weekly.
Associated Press
4 hours ago
- Associated Press
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
CLEVELAND--(BUSINESS WIRE)--Aug 18, 2025-- Centerline Biomedical, Inc. ('Centerline'), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenure, Centerline Biomedical developed, received 510(k) clearance, and commercialized its second-generation devices and appreciable software advances. We appreciate Gulam's significant contributions. 'It is an honor to join Centerline at such a pivotal stage. The IOPS platform is poised for scaled growth and I am grateful to have the opportunity to lead the company as it continues to innovate such remarkable technology for patients and care givers,' said Mr. Dillon. 'With decades of med tech industry leadership, Jim brings deep cardiovascular sector experience leading portfolio innovation, operational alignment, and strategic financing for med tech companies,' said Todd Schwarzinger, Centerline's Chairman. 'Jim has a strong track record of driving commercial growth through category creation and market penetration and we are excited to have him leading Centerline.' Mr. Dillon has previously served as President and CEO for cardiovascular innovation companies; BiVACOR, BioVentrix, Reprieve Cardiovascular and Renal Guard Solutions. To learn more about the IOPS platform, visit About Centerline Biomedical Founded in 2015, Centerline Biomedical, Inc. is headquartered in Cleveland, Ohio. The company's commercially available platform, IOPS® (Intra-Operative Positioning System), enables improved visualization and device navigation, while protecting patient and healthcare provider exposure from the harmful effects of fluoroscopic X-ray radiation during standard interventions. The company is a Cleveland Clinic Innovations spin-off investing in commercialization and development of technology to improve image guidance and reduce the need for fluoroscopic x-ray during transcatheter procedures. IOPS is indicated for use in the peripheral, aortic and aortic side branch vasculature. The IOPS platform consists of a mobile cart powered by proprietary visualization software and intelligent, sensorized IOPS catheters and guidewires. Visit for more information. View source version on CONTACT: For inquiries, please contact: Patty Burns, SVP Marketing Centerline Biomedical, Inc. Email:[email protected] KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: CARDIOLOGY SOFTWARE RADIOLOGY HEALTH MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY TECHNOLOGY SOURCE: Centerline Biomedical, Inc. Copyright Business Wire 2025. PUB: 08/18/2025 11:00 AM/DISC: 08/18/2025 11:00 AM
